Virdante Pharmaceuticals Secures Funding to Improve Antibody-based Therapeutics for Autoimmune and Inflammatory Disorders
Michael DeMane joins Thomas, McNerney & Partners as Senior Advisor
Atritech completes $30 million financing
© 2010 Thomas McNerney & Partners - All Rights Reserved.
